Journal
BIOMATERIALS
Volume 28, Issue 34, Pages 5028-5032Publisher
ELSEVIER SCI LTD
DOI: 10.1016/j.biomaterials.2007.07.048
Keywords
tissue engineered blood vessels; bypass grafting
Funding
- NHLBI NIH HHS [R01 HL041272, R01 HL041272-17, F32 HL078151, F32 HL078151-01, F32 HL078151-02, R01 HL041272-18, R01 HL041272-15, R01 HL041272-16, R01 HL041272-14] Funding Source: Medline
Ask authors/readers for more resources
Cardiovascular disease continues to be the leading cause of death worldwide, and the prevalence of cardiovascular disease has reached epidemic proportions worldwide. Not surprisingly this has led to an increasing number of vascular procedures annually. Unfortunately, the success of these procedures over time continues to limit their long-term effects. Biomedical engineering approaches to improve upon current prosthetic grafts, developing new prosthetic grafts, and creating tissue engineered blood vessels for clinical application offer hope of improving the durability of vascular interventions and improving patients' treatment for cardiovascular disease. (C) 2007 Elsevier Ltd. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available